2-氨基-4-异丙基噻唑 | 79932-20-0

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 2-氨基-4-异丙基噻唑
• 中文别名: 4-异丙基-1,3-噻唑-2-胺
• 英文名称: 2-Amino-4-isopropylthiazole
• 英文别名: 4-isopropylthiazol-2-amine；4-Isopropyl-1,3-thiazol-2-amine；4-propan-2-yl-1,3-thiazol-2-amine
• CAS: 79932-20-0
• 化学式: C₆H₁₀N₂S
• mdl: MFCD07625985
• 分子量: 142.225
• InChiKey: LGPVXXJBWWYOSL-UHFFFAOYSA-N

物化性质

• 熔点：
  48-50 °C
• 沸点：
  105-107 °C(Press: 0.5 Torr)
• 密度：
  1.142±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于丙酮（少许）、DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  67.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2934100090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温且干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Isopropyl-1,3-thiazol-2-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Isopropyl-1,3-thiazol-2-amine
CAS number: 79932-20-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H10N2S
Molecular weight: 142.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-4-异丙基噻唑 在 一氯化碘 、 溶剂黄146 作用下， 以 二氯甲烷 为溶剂， 生成 5-iodo-4-isopropyl-thiazol-2-ylamine
  参考文献：
  名称：

  NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES

  摘要：

  式(I)的化合物以及其药用可接受的盐和酯，其中R1至R3具有权利要求1中给定的含义，并可用于制成药物组合物。

  公开号：

  US20090143448A1
• 作为产物：
  描述：

  1-溴-3-甲基-2-丁酮 在 硫脲 作用下， 以 乙醇 为溶剂， 生成 2-氨基-4-异丙基噻唑
  参考文献：
  名称：

  NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES

  摘要：

  式(I)的化合物以及其药用可接受的盐和酯，其中R1至R3具有权利要求1中给定的含义，并可用于制成药物组合物。

  公开号：

  US20090143448A1

文献信息

• [EN] 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS<br/>[FR] DÉRIVÉS D'AZÉTIDINE OU DE CYCLOBUTANE 1,3-DISUBSTITUÉS UTILISÉS COMME INHIBITEURS DE LA PROSTAGLANDINE D SYNTHASE HÉMATOPOÏÉTIQUE (H-PGDS)
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2018069863A1

  公开（公告）日：2018-04-19

  A compound of formula (I), wherein R, R1, R2, R3, Y, Y1, a, X, and Z are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  式（I）的化合物，其中R、R1、R2、R3、Y、Y1、a、X和Z的定义如本文所述。本发明的化合物是造血前列腺素D合成酶（H-PGDS）的抑制剂，可用于治疗杜兴氏肌肉萎缩症。因此，本发明进一步涉及包含本发明化合物的药物组合物。本发明还进一步涉及使用本发明化合物或包含本发明化合物的药物组合物来抑制H-PGDS活性和治疗相关疾病的方法。
• THIAZOLES: II. PREPARATION OF ALKYL-2-NITRAMINOTHIAZOLES
  作者：Sidney Kasman、Alfred Taurins

  DOI：10.1139/v56-164

  日期：1956.9.1

  1-Chloro-3-methyl-2-butanone and 2-amino-4-isopropylthiazole have been synthesized. The mononitration of 2-aminothiazole and five alkyl-2-aminothiazoles in the 2-amino group has been carried out with absolute nitric acid in concentrated sulphuric acid at low temperatures ranging from 0° to −10°. 2-Nitramino- and alkyl-2-nitramino-thiazoles are crystalline, stable compounds. The dinitration of some alkyl-2-aminothiazoles under the same conditions lead to the formation of alkyl-2-nitramino-5-nitrothiazoles. The rearrangement of 2-nitraminothiazole to 2-amino-5-nitrothiazole was studied in the presence of mesitylene for the first time.

  1-氯-3-甲基-2-丁酮和2-氨基-4-异丙基噻唑已经合成。在浓硫酸中，用绝对硝酸在0°至-10°的低温下对2-氨基噻唑和五种烷基-2-氨基噻唑的2-氨基基团进行了单硝化反应。2-硝基氨基和烷基-2-硝基氨基噻唑是结晶稳定的化合物。在相同条件下，对一些烷基-2-氨基噻唑进行二硝化反应会形成烷基-2-硝基氨基-5-硝基噻唑。首次在间二甲苯存在下研究了2-硝基氨基噻唑重排成2-氨基-5-硝基噻唑。
• [EN] COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS
  申请人：FOGHORN THERAPEUTICS INC

  公开号：WO2019152437A1

  公开（公告）日：2019-08-08

  The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

  本公开涉及用于治疗BAF复合物相关疾病的化合物。
• [EN] MODIFIED PROTEINS AND PROTEIN DEGRADERS<br/>[FR] PROTÉINES MODIFIÉES ET AGENTS DE DÉGRADATION DE PROTÉINES
  申请人：CULLGEN SHANGHAI INC

  公开号：WO2021239117A1

  公开（公告）日：2021-12-02

  Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.

  本文提供了结合或降解靶蛋白的化合物、药物组合物和方法。本文还提供了具有DNA损伤结合蛋白1（DDB1）结合基团的化合物。其中一些实施例包括连接物。其中一些实施例包括靶蛋白结合基团。本文还提供了配体-DDB1复合物。本文还提供了体内修饰的DDB1蛋白。
• Products of the nitration of 2-thiazolylureas and 2-thiazolylthioureas.
  作者：REIKO YODA、YUICHI YAMAMOTO、TOMOKO OKADA、YOSHIKAZU MATSUSHIMA、YOICHI IITAKA

  DOI：10.1248/cpb.32.3483

  日期：——

  Products of the nitration of 2-thiazolylurea and 2-thiazolylthiourea derivatives with fuming nitric acid in concentrated sulfuric acid are described. The urea derivatives studied were 3-(4-methyl-2-thiazoly) urea and -thiourea (7), and their l-methyl (1 and 2, respectively) and 1, 1-dimethyl analogs. The products were the compounds nitrated at the 5-position of the thiazole moiety. With an excess of nitric acid, 1-methyl-3-(4-methyl-5-nitro-2-thiazolyl)-1-nitrourea was obtained from 1, while the corresponding 1-nitrosourea was formed from 2. A pale yellow compound was obtained from the nitration of 7. Unlike other nitrated thioureas, it did not form a colored Cu (II) chelate and was stable to acid, alkali, and heat. It was concluded to be 6-methyl-2-nitroiminothiazolo [3, 2-b] [1, 2, 4] thiadiazole from studies of its physicochemical properties, chemical reactions, and the results of X-ray crystallography. Corresponding compounds were obtained from other N-(4-alkyl-2-thiazolyl) thioureas.

  报道了2-噻唑基脲和2-噻唑基硫脲衍生物在浓硫酸中与发烟硝酸的硝化产物。研究的脲衍生物为3-(4-甲基-2-噻唑基)脲和硫脲(7)及其1-甲基(分别为1和2)和1,1-二甲基类似物。产物是噻唑部分的5-位发生硝化的化合物。当硝酸过量时，从1得到1-甲基-3-(4-甲基-5-硝基-2-噻唑基)-1-硝基脲，而从2得到相应的1-亚硝基脲。硝化7得到一种淡黄色化合物。与其他硝化硫脲不同，它不形成有色Cu(II)螯合物，且对酸、碱和热稳定。根据其物理化学性质、化学反应和X射线晶体学结果，推断为6-甲基-2-硝亚氨基噻唑并[3,2-b][1,2,4]噻二唑。从其他N-(4-烷基-2-噻唑基)硫脲也得到了相应的化合物。